Clinical Study
Mean Platelet Volume in Hyperthyroid Toxic Adenoma Patients after Radioactive 131I Treatment
Table 3
The clinical and biochemical features of patients before and after RAI treatment.
| | | Before RAI treatment | After RAI treatment |
| | Triglyceride (mg/dL) | 162.67 ± 109.17 | 154.08 ± 77.34 | | Total cholesterol (mg/dL) | 184.87 ± 35.82 | 187.48 ± 34.90 | | HDL-C (mg/dL) | 48.00 ± 11.50 | 46.80 ± 10.96 | | LDL-C (mg/dL) | 110.96 ± 39.73 | 122.60 ± 31.76 | | FT3 (pg/mL) | 4.54 ± 1.67 | 3.03 ± 0.54 | | FT4 (pg/mL) | 1.42 ± 0.66 | 1.12 ± 0.28 | | TSH (μIU/mL) | 0.27 ± 0.69 | 1.88 ± 1.54 |
|
|
HDL: high-density lipoprotein; LDL: low-density lipoprotein; TSH: thyroid stimulating hormone.
|
